Mochida Pharmaceutical Co., Ltd. Financial Overview
Mochida Pharmaceutical Co., Ltd.'s market cap is currently ¥115.87B. The company's EPS TTM is ¥55.36; its P/E ratio is 17.97; and it has a dividend yield of 2.30%. Mochida Pharmaceutical Co., Ltd. is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
